Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fuji
Federal Trade Commission
Julphar
Teva
Accenture
Deloitte
Cipla
Harvard Business School

Generated: June 24, 2018

DrugPatentWatch Database Preview

M-PREDROL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do M-predrol patents expire, and what generic alternatives are available?

M-predrol is a drug marketed by Bel Mar and is included in two NDAs.

The generic ingredient in M-PREDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
Summary for M-PREDROL
Drug patent expirations by year for M-PREDROL
Synonyms for M-PREDROL
(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate
2-[(1S,2R,8S,10S,11S,14R,15S,17S)-14,17-DIHYDROXY-2,8,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL ACETATE
200M356
21-Acetoxy-11|A,17-dihydroxy-6|A-methylpregna-1,4-diene-3,20-dione
43502P7F0P
53-36-1
54299-EP2308562A2
54299-EP2371811A2
6-METHYLPREDNISOLONE ACETATE
6.alpha.-Methylprednisolone 21-acetate
6.alpha.-Methylprednisolone acetate
6|A-Methyl Prednisolone 21-Acetate
6alpha-Methyl Prednisolone 21-Acetate
6alpha-Methylprednisolone 21-acetate
6alpha-Methylprednisolone acetate
A19446
AB00375925-05
AC1L1LBW
acetyl-methylprednisolone
AKOS015969745
AN-9611
BDBM233194
Bio-0659
C-22293
C08179
CAS-53-36-1
CC-30908
CHEBI:6889
CHEMBL1364144
component of Neo-Medrol
CPD000718757
D-Med
D00979
depMedalone 40
depMedalone 80
Depo-Medrate
Depo-Medrin
Depo-medrol
Depo-medrol (TN)
Depo-Medrone
Depo-methylprednisolone
Depo-Methylprednisolone acetate
Depomedrone
Depometicort
Depot-Medrol
DSSTox_CID_3302
DSSTox_GSID_23302
DSSTox_RID_76966
DTXSID7023302
EINECS 200-171-3
HMS2233N14
HMS3259L07
Lemod Depo
LS-118505
Medrol acetate
Medrol Enpak
Mepred
methyl prednisolone 21-acetate
Methylprednisolon-21-acetat
Methylprednisolone 21-acetate
Methylprednisolone 21-acetate; Depo-medrate
Methylprednisolone acetate
Methylprednisolone acetate (JAN/USP)
Methylprednisolone acetate [USAN:JAN]
Methylprednisolone acetate [USP:JAN]
methylprednisolone-21-acetate
methylprednisoloneacetate
MLS001304003
MLS002667229
MolPort-002-528-604
NC00628
NCGC00159503-02
NSC 48985
NSC-48985
NSC48985
PL000360
PLBHSZGDDKCEHR-LFYFAGGJSA-N
Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate
Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate (8CI)
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6-alpha,11-beta)-
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
SAM002699893
SCHEMBL13231
SMR000718757
Solsolona
Solsolona [inj.]
Tox21_111722
U 8210
Ubrason
Ubrason [inj.]
Unidrol
UNII-43502P7F0P
Urbason crystal suspension
Vetacortyl
ZINC118912449

US Patents and Regulatory Information for M-PREDROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar M-PREDROL methylprednisolone acetate INJECTABLE;INJECTION 086666-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bel Mar M-PREDROL methylprednisolone acetate INJECTABLE;INJECTION 087135-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
UBS
Healthtrust
Chubb
Boehringer Ingelheim
Covington
Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.